(INVE-B) Investor ser. - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015811963
INVE-B: Health, Finance, It, Equity, Investments, Capital
Investor AB (publ) is one of the oldest and most established private equity firms globally, with a rich history dating back to 1916. Headquartered in Stockholm, Sweden, the firm operates with a dual strategy, focusing on both core investments and operating investments. For its core investments, it targets mature, middle-market buyouts and growth capital opportunities, primarily in the healthcare, financial services, IT, and fintech sectors. The firm is not afraid to take leading minority positions in listed companies, demonstrating its flexibility and strategic approach to value creation.
Geographically, Investor AB casts a wide net. While its operating investments are concentrated on medium-to-large-sized companies headquartered in Northern Europe, the firm also actively pursues opportunities in North Africa, Sub-Saharan Africa, Asia-Pacific, and Latin America, among other regions. This global outlook is complemented by a local touch, as it has deep expertise in navigating the complexities of markets like the Nordics, the Baltics, and the British Isles. The firm’s investment size typically ranges between SEK 20 million ($1.83 million) and SEK 200 million ($18.28 million), allowing it to target a broad spectrum of companies, from emerging players to established market leaders.
Investor AB employs a disciplined approach to its investments. For its operating investments, it seeks controlling stakes or significant minority positions, often taking an active role through board membership to drive strategic decisions and operational improvements. In contrast, its financial investments are typically minority stakes with a shorter investment horizon, focusing on financial holdings that offer attractive returns without the need for active involvement. The firm’s private equity investments are generally held for three to seven years, reflecting its patient, long-term approach to building value.
From a financial perspective, Investor AB is a formidable player, with a market capitalization of 969.086 billion SEK. The stock currently trades at a P/E ratio of 8.55, reflecting its stable earnings and mature business model. The price-to-book (P/B) ratio of 1.19 indicates that the market values the company’s assets at a modest premium, suggesting a balance between growth and stability. The price-to-sales (P/S) ratio of 3.66 further underscores its ability to generate revenue and cash flow from its diversified portfolio.
For investors and fund managers, Investor AB offers a unique combination of historical pedigree, strategic focus, and global reach. Its ability to balance private equity investments with financial holdings provides a diversified approach to capital deployment
Additional Sources for INVE-B Stock
INVE-B Stock Overview
Market Cap in USD | 94,772m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Environmental & Facilities Services |
IPO / Inception |
INVE-B Stock Ratings
Growth 5y | 91.1% |
Fundamental | 47.0% |
Dividend | 66.8% |
Rel. Strength Industry | 7.76 |
Analysts | - |
Fair Price Momentum | 340.76 SEK |
Fair Price DCF | 229.94 SEK |
INVE-B Dividends
Dividend Yield 12m | 3.34% |
Yield on Cost 5y | 10.77% |
Annual Growth 5y | 16.36% |
Payout Consistency | 91.6% |
INVE-B Growth Ratios
Growth Correlation 3m | 74.1% |
Growth Correlation 12m | 86.7% |
Growth Correlation 5y | 91.7% |
CAGR 5y | 26.58% |
CAGR/Max DD 5y | 0.87 |
Sharpe Ratio 12m | 1.02 |
Alpha | 8.68 |
Beta | 0.69 |
Volatility | 28.42% |
Current Volume | 3287.3k |
Average Volume 20d | 3265.5k |
As of March 12, 2025, the stock is trading at SEK 302.70 with a total of 3,287,348 shares traded.
Over the past week, the price has changed by -2.53%, over one month by -3.81%, over three months by +1.02% and over the past year by +16.96%.
Partly, yes. Based on ValueRay Fundamental Analyses, Investor ser. (ST:INVE-B) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.00 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INVE-B as of March 2025 is 340.76. This means that INVE-B is currently undervalued and has a potential upside of +12.57% (Margin of Safety).
Investor ser. has no consensus analysts rating.
According to ValueRays Forecast Model, INVE-B Investor ser. will be worth about 381.7 in March 2026. The stock is currently trading at 302.70. This means that the stock has a potential upside of +26.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 335.3 | 10.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 381.7 | 26.1% |